Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 3/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.35 |
| ▸ | TK1 | P04183 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 3/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26623259 | 1.00 | CASP3 (0.35) | CASP3CASP1CASP8TK1NFKB1 | |
| SCHEMBL26623252 | 1.00 | CASP3 (0.35) | CASP3CASP1CASP8TK1NFKB1 | |
| SCHEMBL25274007 | 0.83 | BRD4 (0.34) | CASP3CASP1CASP8TK1ALDH1A1 | |
| SCHEMBL25262408 | 0.83 | BRD4 (0.34) | CASP3CASP1CASP8TK1ALDH1A1 | |
| SCHEMBL25268709 | 0.83 | BRD4 (0.34) | CASP3CASP1CASP8TK1ALDH1A1 | |
| SCHEMBL25220381 | 0.83 | BRD4 (0.34) | CASP3CASP1CASP8TK1ALDH1A1 | |
| SCHEMBL29317498 | 0.80 | SMN1; SMN2 (0.35) | CASP3CASP1CASP8TK1SMN1; SMN2 | |
| SCHEMBL6160192 | 0.79 | CASP3 (0.33) | CASP3CASP1CASP8 | |
| SCHEMBL12031739 | 0.79 | PRCP (0.43) | CASP3CASP1CASP8 | |
| SCHEMBL29700980 | 0.79 | PRCP (0.43) | CASP3CASP1CASP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1511749-A1 | NOVEL INTERLEUKIN-1BETA CONVERTING ENZYME INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2005-03-09 | — | — | EP | disclosed |
| EP-1511491-A1 | DERIVATIVES OF AZEPINE AND THIAZEPAN AS INTERLEUKIN CONVERTING ENZYME INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2005-03-09 | — | — | EP | disclosed |
| WO-2003103677-A1 | DERIVATIVES OF AZEPINE AND THIAZERAN AS INTERLEUKIN CONVERTING ENZYME INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2003-12-18 | — | — | WO | disclosed |
| WO-2003104231-A1 | NOVEL INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2003-12-18 | — | — | WO | disclosed |
| EP-0998470-B1 | METHOD FOR PREPARING ALKYLOXY FURANONE DERIVATIVES, COMPOUNDS OBTAINED BY SAID METHOD AND USE OF SAID COMPOUNDS | AVENTIS PHARMA SA (FR) | 2003-05-07 | — | — | EP | disclosed |
| US-6235899-B1 | SYNTHESIS OF COMPOUNDS WHICH INHIBIT INTERLEUKIN-1BETA CONVERTING ENZYME. | HOECHST MARION ROUSSEL (FR) | 2001-05-22 | — | — | US | disclosed |
| EP-0998470-A1 | METHOD FOR PREPARING ALKYLOXY FURANONE DERIVATIVES, COMPOUNDS OBTAINED BY SAID METHOD AND USE OF SAID COMPOUNDS | HOECHST MARION ROUSSEL (FR) | 2000-05-10 | — | — | EP | disclosed |
| WO-1999003852-A1 | METHOD FOR PREPARING ALKYLOXY FURANONE DERIVATIVES, COMPOUNDS OBTAINED BY SAID METHOD AND USE OF SAID COMPOUNDS | HOECHST MARION ROUSSEL (FR) | 1999-01-28 | — | — | WO | disclosed |